Ad is loading...
LGOAX
Price
$38.14
Change
-$0.44 (-1.14%)
Updated
Nov 15 closing price
VEXAX
Price
$146.43
Change
-$1.91 (-1.29%)
Updated
Nov 15 closing price
Ad is loading...

LGOAX vs VEXAX

Header iconLGOAX vs VEXAX Comparison
Open Charts LGOAX vs VEXAXBanner chart's image
Patient Opportunity A
Price$38.14
Change-$0.44 (-1.14%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index Admiral
Price$146.43
Change-$1.91 (-1.29%)
VolumeN/A
CapitalizationN/A
LGOAX vs VEXAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGOAX vs. VEXAX commentary
Nov 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGOAX is a Buy and VEXAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 107B vs. LGOAX (1.61B). VEXAX pays higher dividends than LGOAX: VEXAX (1.20) vs LGOAX (0.00). LGOAX was incepted earlier than VEXAX: LGOAX (16 years) vs VEXAX (24 years). LGOAX is a more actively managed with annual turnover of: 40.00 vs. VEXAX (11.00). LGOAX has a lower initial minimum investment than VEXAX: LGOAX (1000) vs VEXAX (3000). LGOAX annual gain was more profitable for investors over the last year : 48.81 vs. VEXAX (33.93). VEXAX return over 5 years is better than : 60.98 vs. LGOAX (40.17).
LGOAXVEXAXLGOAX / VEXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years24 years-
Gain YTD26.37517.699149%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.61B107B2%
Annual Yield % from dividends0.001.20-
Returns for 1 year48.8133.93144%
Returns for 3 years-13.98-2.32603%
Returns for 5 years40.1760.9866%
Returns for 10 years99.65131.6176%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CULP5.070.04
+0.80%
Culp
KKR150.02-0.50
-0.33%
KKR & Co
ZH3.47-0.06
-1.70%
Zhihu
RH315.70-7.13
-2.21%
RH
IMCR31.59-1.03
-3.16%
Immunocore Holdings plc